Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of a monoclonal antibody therapy for ovarian, fallopian tube, and primary peritoneal cancer sponsored by AltaRex.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Monoclonal antibody therapy (unspecified)

Snippet

Sponsor: AltaRex | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 2 | Status: UNKNOWN